Related Experiment Videos
Analgesic domains of interferon-alpha
1Department of Neurobiology, Institute of Neuroscience, China Medical University, Shenyang, PR China.
Neuroreport
|March 30, 2001
Summary
Interferon-alpha (IFNalpha) has both immune and pain-relieving effects. Mutating a specific phenylalanine residue (36th Phe) eliminated pain relief while preserving antiviral activity, identifying it as crucial for IFNalpha
Area of Science:
- Biochemistry
- Immunology
- Neuroscience
Background:
- Interferon-alpha (IFNalpha) exhibits dual functions as an immunoregulatory and analgesic factor.
- Previous research suggested distinct domains within IFNalpha mediate immune and analgesic effects.
- The analgesic domain was hypothesized to be located near the 122nd Tyrosine (Tyr) residue in IFNalpha's tertiary structure.
Purpose of the Study:
- To investigate the role of specific residues in the analgesic activity of Interferon-alpha.
- To determine if the 36th Phenylalanine (Phe) residue contributes to the analgesic domain of IFNalpha.
Main Methods:
- Site-directed mutagenesis was employed to alter the 36th Phe residue of IFNalpha to Serine (Ser).
- The analgesic and antiviral activities of the wild-type and mutant IFNalpha were assessed.
Main Results:
- Mutation of the 36th Phe residue to Ser resulted in a complete loss of analgesic activity.
- The mutant IFNalpha retained significant antiviral activity, approximately 40.5% of the wild-type.
- This indicates the 36th Phe residue is integral to the analgesic function of IFNalpha.
Conclusions:
- The 36th Phenylalanine (Phe) residue is a key component of the analgesic domain of Interferon-alpha (IFNalpha).
- The analgesic domain of IFNalpha likely comprises the 122nd Tyrosine (Tyr) and surrounding residues, including the 36th Phe, in its tertiary structure.